TheStreet reaffirmed their buy rating on shares of UnitedHealth Group (NYSE:UNH) in a report issued on Tuesday, Analyst Ratings.Net reports.
“UnitedHealth Group (UNH) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-. The company’s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins.,” TheStreet’s analyst wrote.
Shares of UnitedHealth Group (NYSE:UNH) traded down 0.86% on Tuesday, hitting $73.0978. 3,467,856 shares of the company’s stock traded hands. UnitedHealth Group has a 1-year low of $51.36 and a 1-year high of $75.88. The stock has a 50-day moving average of $70.84 and a 200-day moving average of $69.80. The company has a market cap of $73.592 billion and a price-to-earnings ratio of 13.95. UnitedHealth Group also was the target of unusually large options trading on Tuesday. Stock traders bought 26,266 call options on the stock. This is an increase of 314% compared to the typical daily volume of 6,348 call options.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, October 17th. The company reported $1.53 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.52 by $0.01. The company had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $30.80 billion. During the same quarter last year, the company posted $1.50 earnings per share. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group will post $5.49 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, December 17th. Investors of record on Friday, December 6th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend is Wednesday, December 4th.
Several other analysts have also recently commented on the stock. Analysts at UBS AG raised their price target on shares of UnitedHealth Group from $81.00 to $84.00 in a research note to investors on Monday, November 25th. They now have a buy rating on the stock. Separately, analysts at Morgan Stanley initiated coverage on shares of UnitedHealth Group in a research note to investors on Thursday, November 21st. They set an overweight rating and a $84.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $80.00 to $84.00 in a research note to investors on Wednesday, November 20th. They now have an overweight rating on the stock. Seven equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average price target of $78.56.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.